Table 3.
Clinical factors with high expression of serum miR-1290
High expression of serum miR-1290 (n = 13) | Univariatea P value |
Multivariateb | ||
OR (95% CI) | P value | |||
Age, n (%) | ||||
<70 yr | 6/13 (46.1) | 1.00 | ||
≥70 yr | 7/13 (53.8) | |||
Sex, n (%) | ||||
Male | 5/10 (50.0) | 1.00 | ||
Female | 8/16 (50.0) | |||
Location, n (%) | ||||
Right colon | 7/19 (36.8) | 0.07 | Reference | |
Left colon | 6/7 (85.7) | 5.59 (0.26–118.23) | 0.27 | |
Macroscopic type, n (%) | ||||
Protruding | 1/3 (33.3) | 0.14 | Reference | |
LST-G | 10/15 (66.7) | 15.6 (0.34–710.67) | 0.16 | |
LST-NG | 2/8 (25.0) | 11.3 (0.15–829.61) | 0.27 | |
Tumor size, n (%) | ||||
<12.6 cm2 | 11/13 (84.6) | <0.01 | Reference | |
≥12.6 cm2 | 2/13 (15.4) | 33.1 (1.97–556.64) | 0.02 | |
Vienna Classification, n (%) | ||||
Category 3 | 6/14 (42.9) | 0.70 | ||
Category 4 | 7/12 (58.3) |
Factors with P value of less than 0.2 in univariate analysis were included in multivariate analyses.
CI, confidence interval; LST-G, laterally spreading tumor granular type; LST-NG, laterally spreading tumor nongranular type; OR, odds ratio.
Chi-square test or Fisher's exact probability test.
Multiple logistic regression analysis.